Smithtown Assisted Living
(516) 265-7793
RA: Background Dose Doesn't Matter With JAK Inhibitor (CME/CE)
(MedPage Today) -- Efficacy seen whether methotrexate dose was low or high with Xeljanz
via
RA: Background Dose Doesn't Matter With JAK Inhibitor (CME/CE)
by
Newer Post
Older Post
Home